Skip to main content

Linguamatics Says 2009 Revenues Topped $5M

Premium

Linguamatics, a text-mining firm based in Cambridge, UK, said this week that its 2009 revenue exceeded $5 million, which represented 50 percent year-over-year growth.

The privately held firm attributed the increase in revenues to improved sales of software licenses and "associated professional services."

Linguamatics' growth reflects its ability to "respond effectively to expanding demand for text mining" using its I2E software platform, John Brimacombe, executive chairman of Linguamatics, said in a statement.

"We see potential for significant growth to continue in 2010 and beyond," he added.

In February the firm announced it had opened a new regional headquarters in Newton, Mass., to better serve its customers on the East Coast of the US (BioInform, 2/26/2010).

At the time, the company said that it had added several new, undisclosed, pharmaceutical customers during 2009 and expanded deployment of I2E within existing customer sites.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.